Panagora Asset Management Inc Rigel Pharmaceuticals Inc Transaction History

Panagora Asset Management Inc

$20.5 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$1.25 - $2.0 $840,638 - $1.35 Million	-672,511 Reduced 81.63%	151,316 $199,000
Q4 2022 Feb 13, 2023	BUY	$0.67 - $11.9 $126,724 - $2.25 Million	189,141 Added 29.8%	823,827 $1.24 Million
Q3 2022 Nov 14, 2022	BUY	$1.1 - $12.2 $114,900 - $1.27 Million	104,455 Added 19.7%	634,686 $749,000
Q2 2022 Aug 15, 2022	BUY	$0.67 - $3.19 $37,270 - $177,453	55,628 Added 11.72%	530,231 $599,000
Q1 2022 May 12, 2022	BUY	$2.22 - $3.45 $50,152 - $77,938	22,591 Added 5.0%	474,603 $1.42 Million
Q4 2021 Feb 10, 2022	SELL	$2.36 - $3.57 $8,897 - $13,458	-3,770 Reduced 0.83%	452,012 $1.2 Million
Q3 2021 Nov 10, 2021	SELL	$3.5 - $4.5 $578,476 - $743,755	-165,279 Reduced 26.61%	455,782 $1.65 Million
Q2 2021 Aug 11, 2021	SELL	$3.09 - $4.54 $1.85 Million - $2.72 Million	-598,390 Reduced 49.07%	621,061 $2.7 Million
Q1 2021 May 12, 2021	BUY	$3.35 - $4.93 $551,654 - $811,837	164,673 Added 15.61%	1,219,451 $4.17 Million
Q4 2020 Feb 10, 2021	BUY	$2.35 - $3.74 $52,893 - $84,179	22,508 Added 2.18%	1,054,778 $3.69 Million
Q3 2020 Nov 13, 2020	BUY	$1.78 - $4.13 $131,321 - $304,694	73,776 Added 7.7%	1,032,270 $2.48 Million
Q2 2020 Aug 12, 2020	BUY	$1.41 - $2.05 $78,050 - $113,477	55,355 Added 6.13%	958,494 $1.75 Million
Q1 2020 May 14, 2020	SELL	$1.27 - $3.0 $202,738 - $478,911	-159,637 Reduced 15.02%	903,139 $1.41 Million
Q4 2019 Feb 12, 2020	BUY	$1.6 - $2.43 $916,313 - $1.39 Million	572,696 Added 116.86%	1,062,776 $2.27 Million
Q3 2019 Nov 12, 2019	BUY	$1.63 - $2.62 $791,526 - $1.27 Million	485,599 Added 10836.84%	490,080 $916,000
Q2 2019 Aug 09, 2019	BUY	$2.02 - $2.61 $9,051 - $11,695	4,481 New	4,481 $12,000

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account